RATIONALE AND PURPOSE:Motivational interviewing (MI) is a counseling technique that has been used effectively to change a number of health-related behaviors. We sought to assess the impact on patients' antiretroviral therapy (ART) adherence of a multicomponent, MI-based ART adherence intervention compared with that of an HIV informational control program. STUDY DESIGN: Two-arm, randomized, controlled trial. SAMPLE: One hundred forty adult HIV-infected patients attending a large, academic center infectious diseases clinic who were either failing or newly initiating an ART regimen. STUDY ENDPOINTS: (1) Mean adherence level (% of prescribed doses take in the prior month) at the week 12 visit, (2) change in mean adherence, (3) percentage of patients achieving >95% adherence in the third 4-week block, and (4) change in viral load. MAIN FINDINGS: The MI group's mean adherence improved by 4.5% compared with a decrease in the control group's adherence by 3.83% (P = 0.10). In the treatment group, 29% achieved >95% adherence compared with only 17% in the control group (P = 0.13). When we controlled for ethnicity, the intervention group had 2.75 times higher odds of achieving more than 95% adherence than did the controls (P = 0.045; 95% confidence interval: 1.023, 7.398). Although a number of mediating variables (beliefs about ART, coping style, social support, and goals set) had statistically significant changes in the expected direction in the MI group compared with controls, in the intent-to-treat analysis, the mean adherence at study exit for the intervention group was 76% (SD = 27%) and 71% (SD = 27%) for the control group (P = 0.62). CONCLUSION: Although not definitive, this study provides some evidence that MI offers an effective approach to improving adherence. Future studies able to build MI into the intervention for longer than 3 months may have a greater impact.
RCT Entities:
RATIONALE AND PURPOSE: Motivational interviewing (MI) is a counseling technique that has been used effectively to change a number of health-related behaviors. We sought to assess the impact on patients' antiretroviral therapy (ART) adherence of a multicomponent, MI-based ART adherence intervention compared with that of an HIV informational control program. STUDY DESIGN: Two-arm, randomized, controlled trial. SAMPLE: One hundred forty adult HIV-infectedpatients attending a large, academic center infectious diseases clinic who were either failing or newly initiating an ART regimen. STUDY ENDPOINTS: (1) Mean adherence level (% of prescribed doses take in the prior month) at the week 12 visit, (2) change in mean adherence, (3) percentage of patients achieving >95% adherence in the third 4-week block, and (4) change in viral load. MAIN FINDINGS: The MI group's mean adherence improved by 4.5% compared with a decrease in the control group's adherence by 3.83% (P = 0.10). In the treatment group, 29% achieved >95% adherence compared with only 17% in the control group (P = 0.13). When we controlled for ethnicity, the intervention group had 2.75 times higher odds of achieving more than 95% adherence than did the controls (P = 0.045; 95% confidence interval: 1.023, 7.398). Although a number of mediating variables (beliefs about ART, coping style, social support, and goals set) had statistically significant changes in the expected direction in the MI group compared with controls, in the intent-to-treat analysis, the mean adherence at study exit for the intervention group was 76% (SD = 27%) and 71% (SD = 27%) for the control group (P = 0.62). CONCLUSION: Although not definitive, this study provides some evidence that MI offers an effective approach to improving adherence. Future studies able to build MI into the intervention for longer than 3 months may have a greater impact.
Authors: J A Fleishman; C D Sherbourne; S Crystal; R L Collins; G N Marshall; M Kelly; S A Bozzette; M F Shapiro; R D Hays Journal: Am J Community Psychol Date: 2000-08
Authors: H Liu; C E Golin; L G Miller; R D Hays; C K Beck; S Sanandaji; J Christian; T Maldonado; D Duran; A H Kaplan; N S Wenger Journal: Ann Intern Med Date: 2001-05-15 Impact factor: 25.391
Authors: W E Cunningham; L E Markson; R M Andersen; S H Crystal; J A Fleishman; C Golin; A Gifford; H H Liu; T T Nakazono; S Morton; S A Bozzette; M F Shapiro; N S Wenger Journal: J Acquir Immune Defic Syndr Date: 2000-10-01 Impact factor: 3.731
Authors: Edwin B Fisher; Carol A Brownson; Mary L O'Toole; Gowri Shetty; Victoria V Anwuri; Russell E Glasgow Journal: Am J Public Health Date: 2005-07-28 Impact factor: 9.308
Authors: A Tuldrà; C R Fumaz; M J Ferrer; R Bayés; A Arnó; M Balagué; A Bonjoch; A Jou; E Negredo; R Paredes; L Ruiz; J Romeu; G Sirera; C Tural; D Burger; B Clotet Journal: J Acquir Immune Defic Syndr Date: 2000-11-01 Impact factor: 3.731
Authors: P J Weidle; C E Ganera; K L Irwin; J P McGowan; J A Ernst; N Olivo; S D Holmberg Journal: J Acquir Immune Defic Syndr Date: 1999-12-15 Impact factor: 3.731
Authors: Andrea Sankar; Carol Golin; Jane M Simoni; Mark Luborsky; Cynthia Pearson Journal: J Acquir Immune Defic Syndr Date: 2006-12-01 Impact factor: 3.731
Authors: Timothy J Arentsen; Stella Panos; April D Thames; J Natalie Arbid; Steven A Castellon; Charles H Hinkin Journal: J HIV AIDS Soc Serv Date: 2016-09-23
Authors: Bryan Hartzler; Julia C Dombrowski; Jason R Williams; Heidi M Crane; Joseph J Eron; Elvin H Geng; Christopher Mathews; Kenneth H Mayer; Richard D Moore; Michael J Mugavero; Sonia Napravnik; Benigno Rodriguez; Dennis M Donovan Journal: AIDS Behav Date: 2018-03
Authors: Daniel H Solomon; Maura D Iversen; Jerry Avorn; Timothy Gleeson; M Alan Brookhart; Amanda R Patrick; Laura Rekedal; William H Shrank; Joyce Lii; Elena Losina; Jeffrey N Katz Journal: Arch Intern Med Date: 2012-02-27
Authors: Mahnaz R Charania; Khiya J Marshall; Cynthia M Lyles; Nicole Crepaz; Linda S Kay; Linda J Koenig; Paul J Weidle; David W Purcell Journal: AIDS Behav Date: 2014-04
Authors: Matthias Kalder; Volker Ziller; Ioannis Kyvernitakis; Dana Knöll; Olaf Hars; Peyman Hadji Journal: J Cancer Res Clin Oncol Date: 2013-02-27 Impact factor: 4.553
Authors: T Gleeson; M D Iversen; J Avorn; A M Brookhart; J N Katz; E Losina; F May; A R Patrick; W H Shrank; D H Solomon Journal: Osteoporos Int Date: 2009-06-05 Impact factor: 4.507